Active

F-Prime Capital

Investor type

VC

Founded

1969

AUM

$4 500 M

Location

Cambridge, Massachusetts, United States

Investment Ticket

$0-1 m

Investment Stage

Seed Series B

Region of investment

North America Europe
Investor profile last updated: 20 May, 2025

Profile

Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx.

Today our funds are larger and more global, but our teams are still small and local. We stay true to our entrepreneurial roots. In the US and Europe, we are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, our sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together we bring a world of insight, domain expertise and relationships to support our entrepreneurs. Without the pressure of fundraising from outside investors, we focus all of our time finding and helping great entrepreneurs build important companies.

Industry

Business Services (B2B) Education Edtech Financial Services Fintech Food and Beverage Foodtech Healthcare Services Industrial IT Services Marketing and Advertising Media and Entertainment Medical Devices Other Robotics SaaS Security Software Telecommunications Travel Blockchain/Crypto AI Life Sciences VR/AR HealthTech Mobility TravelTech Fashion/Beauty Gaming Pharmaceuticals Sports/SportsTech MedTech Infrastructure AdTech Biotechnology

F-Prime Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
F-Prime Capital Partners Life Sciences Fund VI LP
Venture Capital (VC)
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
AI
HealthTech
Pre-seed
Seed
North America
Europe
Asia
$5-10 m
—
June 2012

Contacts

Name
Title
Email
avatar
Carl Bradford Byers Partner
Partner
c•••@•••
avatar
Sandor Palfy Venture Partne
Venture Partne
s•••@•••
Upgrade to see contacts
avatar
VeXOAatLQmD29bxU VeXOAatLQmD29bxU
VeXOAatLQmD29bxU
avatar
VeXOAatLQmD29bxU VeXOAatLQmD29bxU
VeXOAatLQmD29bxU
avatar
VeXOAatLQmD29bxU VeXOAatLQmD29bxU
VeXOAatLQmD29bxU
Investment-team contacts for F-Prime Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about F-Prime Capital

F-Prime Capital is a venture capital firm. It backs companies at Seed and Series B, writing tickets of $0-1 m.
F-Prime Capital is located in Cambridge, Massachusetts, United States.
F-Prime Capital was founded in 1969.
F-Prime Capital invests in companies and startups in Business Services (B2B), Education, Edtech, Financial Services, Fintech, Food and Beverage, Foodtech, Healthcare Services, Industrial, IT Services, Marketing and Advertising, Media and Entertainment, Medical Devices, Other, Robotics, SaaS, Security, Software, Telecommunications, Travel, Blockchain/Crypto, AI, Life Sciences, VR/AR, HealthTech, Mobility, TravelTech, Fashion/Beauty, Gaming, Pharmaceuticals, Sports/SportsTech, MedTech, Infrastructure, AdTech, Biotechnology.
F-Prime Capital invests in companies and startups in North America, Europe.
F-Prime Capital invests in companies and startups at Seed, Series B.
F-Prime Capital usually invests $0-1 m on average.
F-Prime Capital has around $4 500m assets under management.
F-Prime Capital last fund was created/launched in 2012-06-06
F-Prime Capital can be reached through its website fprimecapital.com, its LinkedIn page and its X account. Its general enquiries address is nfo@fprimecapital.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for F-Prime Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query F-Prime Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 20 May, 2025. Something out of date here? Report it — we re-run that firm within 48h and get back to you.